4th Quarter - Report

FIDELIS GOVERNMENT RELATIONS for EXELA PHARMA SCIENCES

Period 4th Quarter 2020 Filed Jan 18, 2021 Signed by Terry Allen

Official filing
Firm
FIDELIS GOVERNMENT RELATIONS
Client
EXELA PHARMA SCIENCES
Income
$90,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

federal support for Covid-19 vaccination development and distribution

LobbyistCovered position, as disclosed
TERRY ALLEN Chief of Staff, Rep. Steve Largent
WAYNE KING Deputy Chief of Staff, Rep. Mark Meadows

Contacted: President of the U.S.; SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.